INTRODUCTION

10
All normal cells carry the same DNA sequence, yet distinct cell types result from 11 gene expression patterns that are controlled by a combination of genetic and 12 epigenetic mechanisms. In cancer, genetic and epigenetic changes result in altered 13 gene expression patterns, such as up-regulation of oncogenes and down-regulation of 14 tumour-suppressor genes (Stratton 2011; Jones and Baylin 2007) . Specifically, 15 mutations in the DNA sequence or changes in copy number can alter how these genes 16 are regulated or expressed, as can non-sequence epigenetic features, such as chemical 17 (e.g. DNA methylation or histone modifications) or structural makeup (e.g. 18 nucleosome occupancy). Advances in microarray and especially HTS technologies 19 have driven a deeper exploration of genetic and epigenetic phenomena, resulting in 20 several large data collection projects (Stratton 2011; Jones et al. 2008; Bernstein et al. 21 2010; International Cancer Genome Consortium 2010) as well as many smaller scale 22 studies. Statistical and computational tools for processing and interpreting these 23 datasets are maturing, and altogether these give exciting prospects for the 24 understanding, detection, prevention, and treatment of cancer and other diseases. developed to post-process output from absolute algorithms into merged regions and 5 perform differential analysis based on read densities (Ross-Innes et al. 2012) . 6
A separate class of methods are available to directly detect differential regions, often 7 without the use of input or other control samples (see Table 1 for list of assays and 8 acronyms). For example, Bock et al. detected changes in read density using Fisher's 9 exact test; CNV is deemed unimportant in their analysis despite no CNV-typing 10 (Bock et al. 2010) . Another strategy, ChIPDiff, assumes beta-binomially distributed 11 tiled bin counts and uses a Hidden Markov Model (HMM) to combine adjacent 12 differential regions (Xu et al. 2008) . Similarly, RSEG scans for differential regions 13 using an HMM with a difference-of-negative-binomials emission distribution (Qiang 14 Song and Smith 2011). Other tools are emerging for differential analyses, such as 15 DBChIP (Liang and Keles 2011) or by collecting existing Unix-based tools (Bardet et 16 al. 2011) , but none of these are explicitly CNV-aware. Though specific to DNA 17 methylation, BATMAN, which transforms read densities into absolute methylation 18 estimates, was recently made CNV-aware by first dividing read densities by copy 19 number before differential analysis (Feber et al. 2011; Down et al. 2008) . However, 20 this transformation takes measurements off the count scale, which may affect the 21 sensitivity of subsequent statistical analyses. 22
We propose a flexible and general statistical framework called ABCD-DNA that 23 explicitly adjusts for CNV in differential epigenome analyses. First, we describe the 24 statistical framework, which necessarily involves considerations for the estimation ofCNV and normalization. Second, we illustrate the effects of CNV on various 1 algorithms for differential analysis across multiple qDNA-seq datasets. Using 2 independent truth (DNA methylation levels), we demonstrate improved differential 3 detection performance using CNV-aware analyses. Third, we compare the 4 performance of ABCD-DNA and competing methods, demonstrating the proposed 5 framework is competitive against existing approaches and flexible, irrespective of 6 arrays, DNA methylation estimates at individual CpG sites are summarized as beta 1 values (See Methods). For comparison with the MBDCap-seq data, beta values are 2 averaged over technical replicates and regions of interest. Here, regions of interest 3 comprise non-overlapping 500bp tiled genomic segments where 450k probes exist. 4
The averaged beta values are used to label regions as differentially methylated 5 (change in beta > 0.4), not differentially methylated (change in beta < 0.1) or 6 indeterminate (0.1-0.4). GLMs are fitted using the edgeR package with and without 7 CNV offsets (both use normalization offsets) and ranking of regions is according to 8 likelihood ratio test P-values. Other cutoffs for difference in beta values were tested 9 (data not shown) and the results presented here are representative. 10 Figure 5 shows ROC curves for symmetrically-chosen truly differentially methylated 11 regions (See Methods), stratified by copy number state, comparing CNV-aware 12 ("ABCD-DNA", using either SNP arrays or genomic sequencing for CNV offsets) 13 and CNV-unaware GLM strategies ("Naïve"), RSEG and DiffBind (with and without 14 input subtraction) are also compared (See Methods). Taken together, these results 15 highlight several features of our new method: i) gains in performance can be achieved 16 for non-"neutral" regions; ii) the magnitude of performance gain increases as CNV 17 increases; iii) ABCD-DNA performs equally well, regardless of the source of CNV 18 information (Affymetrix SNP 6.0, low coverage genomic sequencing); iv) ABCD-19 DNA outperforms competing methods. 20
To understand the difference that CNV compensation makes genome-wide to 21 differential detection calls, Supplementary Figure 6 gives Venn diagrams showing 22 the overlap of CNV-Aware and Naïve calls (adjusted P-value < .01) by CNV state; as 23 expected, differential calls in the "neutral" regions are unaffected, while the overlap 24 degrades significantly as CNV increases. Furthermore, to highlight how ABCD-DNAaccording to knowledge of the most prominent copy state (here, LNCaP=4 and 1 PrEC=2). Read densities are then segmented using CBS (Venkatraman and Olshen 2
2007). 3
Choosing regions for ROC analysis "symmetrically"
4
Because the truly differentially methylated regions for the LNCaP versus PrEC 5 comparison are biased towards hypermethylation, we randomly selected the same 6 number of truly hypermethylated and truly hypomethylated regions for the ROC 7 analysis. 8
ROC analysis using RSEG
9
To generate ROC curves for RSEG, we ran rseg-diff repeatedly with different 10 values of the -cdf-cutoff parameter (between 0.01 and 0.40). For each of the 11 truly differentially methylated and non-differentially methylated regions, the score 12 used for ROC analysis was the maximum cdf-cutoff such that the region was deemed 13 differentially enriched, if at all. See Supplementary website describing the commands 14 used for each tool. 15
ROC analysis using DiffBind
16
To generate ROC curves for DiffBind, we set a high P-value threshold when calling 17 dba.report(), thus giving scores for the full list of inputted regions. The score 18 used for ranking was the P-value. Furthermore, whether to subtract input reads was 19 controlled by the bSubControl=FALSE argument in the call to 20 dba.analyze(). Otherwise, default parameters were used. 21
Processing of Illumina HumanMethylation 450k array data
22
The HumanMethylation 450k arrays were processed using the R/Bioconductor 'minfi' 23 package using bg.correct = TRUE and normalize = "controls", to 24
generate beta values. Differences in beta values were used to determine the truly 1 differentially methylated regions. 2
Reproducibility of analyses and figures in this manuscript
3
All data and R code used for the generation of figures in this manuscript are available 4 from <http://imlspenticton.uzh.ch/robinson_lab/ABCD-DNA/> with further 5 description in the Sweave-based Supplementary PDF Document. 6 7
DATA ACCESS
8
Datasets used
9
The following datasets (with NCBI Gene Expression Omnibus accession numbers) 10 were used for the main comparisons: shown in black. Region B) shows a FN for all algorithms except ABCD-DNA; the 10 change in depth-normalized read density is not particularly strong, but combined with 11 the knowledge that this is a "low" copy region (LNCaP=2), ABCD-DNA expects 12 fewer reads. Hence, the effective difference is made larger and therefore deemed 13 differential by ABCD-DNA. Similarly, region C) is amplified in cancer beyond 14 "neutral" (LNCaP=5), thus ABCD-DNA expects higher read density (if methylated) 15 and correctly increases the effective change. Region D) is similarly amplified, which 16 causes existing algorithms to overstate the differential methylation (i.e. a FP); note the 17 upstream differentially methylated region that all algorithms detect, whereas only 18 ABCD-DNA correctly attributes the downstream change in read density to CNV. ABCD-DNA outperforms competing approaches. ROC curves 1 (sensitivity versus 1-specificity) are shown for various differential region detection 2 algorithms operating on MBDCap-seq data, using 450k array data as an independent 3 source of truly and non-truly differentially methylated regions. "Naïve" uses offsets 4 to account for (effective) sequencing depth but not CNV; "ABCD-DNA" uses either 5
Affymetrix SNP 6.0 or genomic sequencing to estimate CNV offsets. "RSEG" 6 denotes running rseg-diff with different sensitivity cutoffs. "DiffBind", which 7
operates on MACS-detected regions, was run both with and without input subtraction. LNCaP copy number (PrEC copy=2) 
